Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Q3 2025 value amounting to $304000.0.

  • Rhythm Pharmaceuticals' Exchange Rate Effect rose 15041.46% to $304000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 18568.98%. This contributed to the annual value of $2000.0 for FY2024, which is 10140.85% up from last year.
  • Rhythm Pharmaceuticals' Exchange Rate Effect amounted to $304000.0 in Q3 2025, which was up 15041.46% from -$279000.0 recorded in Q2 2025.
  • Over the past 5 years, Rhythm Pharmaceuticals' Exchange Rate Effect peaked at $977000.0 during Q4 2024, and registered a low of -$603000.0 during Q3 2024.
  • In the last 3 years, Rhythm Pharmaceuticals' Exchange Rate Effect had a median value of -$71000.0 in 2024 and averaged -$10636.4.
  • Over the last 5 years, Rhythm Pharmaceuticals' Exchange Rate Effect had its largest YoY gain of 60885.42% in 2024, and its largest YoY loss of 88311.69% in 2024.
  • Over the past 3 years, Rhythm Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$192000.0 in 2023, then surged by 608.85% to $977000.0 in 2024, then crashed by 68.88% to $304000.0 in 2025.
  • Its Exchange Rate Effect was $304000.0 in Q3 2025, compared to -$279000.0 in Q2 2025 and -$2000.0 in Q1 2025.